Corbus Pharmaceuticals Holdings (CRBP)CFO sold ~$24K

~$24K

Approx. value · 2,792 sh @ $8.76

73K

Holds after · shares reported

Traded

Feb 14, 2025

Filed

Feb 18, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 14, 2025 · this disclosureInsiderCFO sold ~$24K of CRBP shares in the open market

What came next

1. Feb 14, 2025InsiderCEO sold ~$62K of CRBP shares in the open market
2. Mar 6, 2025InsiderOfficer sold ~$43K of CRBP shares in the open market
3. May 30, 2025Insider · 2 peopleInsiders: 2 sales (~$31K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Corbus Pharmaceuticals Holdings

OQRO holds no insider, Congress, fund or contract record for Corbus Pharmaceuticals Holdings dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRBP page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Corbus Pharmaceuticals Holdings

• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 4Jun 2, 2025
• SEC Form 4Jun 2, 2025
• SEC Form 4Mar 7, 2025
• SEC Form 4Feb 18, 2025

Everything OQRO holds on this company is on its CRBP page.